Filing Flows › InspireMD (NSPR) › Recalls, complaints & regulation
InspireMD (NSPR): recalls and clinical trials
InspireMD (NSPR) beyond its filings: 6 recalls in the last 12 months (6 in five years, 0 Class I); 3 active clinical trials.
Latest recalls
- 2026-06-17 · FDA device · Brand Name: CGuard¿ Prime Carotid Stent System, 135cm, 8mmx40mm Model/Catalog Number: CND0840
- 2026-06-17 · FDA device · Brand Name: CGuard¿ Prime Carotid Stent System, 135cm, 8mmx30mm Model/Catalog Number: CND0830
- 2026-06-17 · FDA device · CGuard Prime Carotid Stent System, 135cm, 9mx30mm Model/Catalog Number: CND0930
- 2026-06-17 · FDA device · CGuard¿ Prime Carotid Stent System, 135cm, 10mmx40mm Model/Catalog Number: CND1040
- 2026-06-17 · FDA device · Brand Name: CGuard Prime Carotid Stent System, 135cm, 9mx40mm Model/Catalog Number: CND0940
- 2026-06-17 · FDA device · CGuard Prime Carotid Stent System, 135cm, 10mmx30mm Model/Catalog Number: CND1030
InspireMD's latest quarter
InspireMD, Q2 2026: revenue $1.8M (-0.4% year over year), operating margin -815.6%, net loss $14.3M, operating cash flow −$10.9M. The chart follows the revenue to costs, profit and cash.
Questions
Has InspireMD had any recalls?
6 recalls on file over five years from the FDA, CPSC and NHTSA; 6 in the last 12 months.
How many clinical trials does InspireMD have?
3 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.